BioWorld - Wednesday, April 1, 2026

BioWorld Science

Aug. 13, 2002

View Archived Issues

Sch-351591 as an effective oral therapy for asthma and COPD

Read More

Potential use of fidarestat in the treatment of diabetic neuropathy

Read More

Resiniferatoxin provides long-lasting pain suppression in rat peripheral nerves

Read More

Telik reviews second quarter progress

Read More

Cancer targets selected from Exelixis and Bristol-Myers Squibb collaboration

Read More

Altea awarded SBIR grant for micropore opioid patch

Read More

Antex antibiotic compound active against anthrax

Read More

Crucell and NIAID expand Ebola vaccine agreement to include Marburg and Lassa vaccines

Read More

InSite Vision and Bausch & Lomb sign agreement for ISV-403 development

Read More

OC-1012 completes phase I trial

Read More

Second phase I study of huN901-DM1 under way

Read More

VNP-40101M enters phase I trial in leukemia

Read More

Nutraceutix changes name to SCOLR

Read More

ConjuChem terminates DAC:TI development

Read More

Novel CCR2 antagonists prepared by BMS researchers

Read More

Schering-Plough presents new cholesterol-lowering agents

Read More

New NPY Y5 antagonists in early development at Schering-Plough

Read More

Novel ITK tyrosine kinase inhibitors and their use covered by BMS patent

Read More

New antibacterial piperazines prepared and tested at GSK

Read More

Aventis discontinues M-100240 development in hypertension

Read More